Home
The Walensky Lab: Stapled BCL-2 Peptides
The Walensky laboratory focuses on the chemical biology of deregulated apoptotic and transcriptional pathways in cancer. Our goal is to develop an arsenal of new compounds-a “chemical toolbox”-to investigate and block protein interactions that cause cancer. To achieve these objectives, we take a multidisciplinary approach that employs synthetic chemistry techniques, structural biology analyses, and biochemical, cellular, and mouse modeling experiments to systematically dissect the pathologic signaling pathways of interest.
Recent News
Fed Bernal Attends Livestrong Summit
Sunday, 17 August 2008
Image
Fed Bernal was invited to attend the 2008 Livestrong Summit at The Ohio State University campus in Columbus, Ohio. The July 24-27 summit included a Town Hall meeting with Senator John McCain. A brief documentary on the event can be viewed here .
 
Welcome Darya Leschiner!
Wednesday, 07 May 2008
Image
Congratulations to Liza and her husband Ignat on the birth of their daughter. Darya weighed in at 8 lb 2 oz and is already 19 inches tall!
 
Sam Katz Honored with a Leukemia and Lymphoma Society Scholar Award
Friday, 11 April 2008
Image
Congratulations to Sam Katz for being awarded a 3-year Leukemia and Lymphoma Society Postdoctoral Fellowship to support his research on the pathogenesis and treatment of refractory lymphoma.
 
Double Congratulations to Craig!
Friday, 14 March 2008
Image
The lab congratulates Craig Braun on passing his chemical biology graduate program qualifying examination and for being awarded a graduate fellowship from the National Sciences and Engineering Research Council of Canada. Nicely done on both fronts!
 
Dr. Walensky Featured on XM Radio
Friday, 07 March 2008
Image
Dr. Walensky was recently interviewed on the ReachMD XM radio program as part of their "Clinician's Roundtable" series. You can download the interview here (~7.5 MB).
 
Fed Bernal Honored with an AACR Meeting Award
Friday, 29 February 2008
Image
Congratulations to Federico Bernal for being selected to receive a Minority Scholar in Cancer Research Award in recognition of his abstract submission to this years' AACR meeting in San Diego.